Main menu

NEW YORK (GenomeWeb News) – Dako has received clearance from the US Food and Drug Administration to expand the intended use of its HercepTest and HER2 FISH pharmDx Kit to include patients with metastatic gastric or gastroesophageal junction adenocarcinoma (stomach cancer).